Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 EPS of ($0.43), $0.02 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $37.9 million versus the consensus estimate of $36.7 million.

For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.